Maintaining “Intensity” for Better Outcomes in AML
1:24:52
Guiding Multifactorial Clinical Decisions in HR+, HER2- Breast Cancer
56:15
The Evolving Role of NGS and Measurable Residual Disease in CLL/SLL and AML
1:34:23
Mastering Myelofibrosis Care
1:02:36
Cancer Revealed: How the Immune System Sees and Destroys Tumors, with Jeffrey Weber
1:00:58
Missing Microbes with Dr Martin Blaser
57:00
Capitalizing on Personalized Care in IDH Mutant Gliomas
24:35
Dr. Catherine Monk: The Mother-Infant Relationship Before Birth & Why it Matters
11:42